Clinical Trials Browser

Terminated × Carcinoma, Hepatocellular × Sunitinib × Clear all

Carcinoma, Hepatocellular

NCT00524316 2017-05-09

Sunitinib and Chemoembolization in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

Phase 2 Terminated

16 enrolled 11 charts

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT01215565 2014-03-13

Fibrolam

Phase 2 Terminated

4 enrolled

Gastrointestinal

Fibrolamellar hepatocellular carcinoma, Adenocarcinoma, Carcinoma, Digestive System Neoplasms, Fibrosis, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial, Pathologic Processes

NCT00699374 2013-01-14

Study Of Sunitinib Malate Versus Sorafenib In Patients With Inoperable Liver Cancer

Phase 3 Terminated

1,075 enrolled 10 charts

Gastrointestinal

Carcinoma, Hepatocellular

Clinical Trials

Sunitinib Malate and Capecitabine in Treating Patients With Unresectable or Metastatic Liver Cancer

Sunitinib and Chemoembolization in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

Fibrolam

Study Of Sunitinib Malate Versus Sorafenib In Patients With Inoperable Liver Cancer